Tango Therapeutics, Inc. (TNGX)
11.14
-0.26
(-2.28%)
USD |
NASDAQ |
Feb 27, 16:00
11.15
+0.01
(+0.09%)
After-Hours: 20:00
Tango Therapeutics Free Cash Flow : -146.76M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AbbVie, Inc. | 17.82B |
| Teleflex, Inc. | 245.44M |
| Recursion Pharmaceuticals, Inc. | -380.44M |
| Amicus Therapeutics, Inc. | 29.85M |
| EyePoint Plc | -213.59M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -30.95M |
| Cash from Investing (Quarterly) | 47.48M |
| Cash from Financing (Quarterly) | 2.541M |
| Free Cash Flow Per Share (Quarterly) | -0.2803 |
| Free Cash Flow to Equity (Quarterly) | -30.86M |
| Free Cash Flow to Firm (Quarterly) | -31.10M |
| Free Cash Flow Yield | -11.96% |